Literature DB >> 28846468

The newly filed patent applications for vaccines against staphylococcus aureus.

Bao-Chi Chang1,2, Shyh-Jen Wang1,3,4.   

Abstract

Staphylococcus aureus (S. aureus) frequently causes life threatening disease. To release the threat, vaccine has been proposed as a preventive intervention against the cause. However, the development of the vaccines is still in early stages. Thus, highlighting the related newly filed patent applications would stimulate further developments.

Entities:  

Keywords:  patent application; staphylococcus aureus; vaccine

Mesh:

Substances:

Year:  2017        PMID: 28846468      PMCID: PMC5703401          DOI: 10.1080/21645515.2017.1361577

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  4 in total

1.  The drug-resistant bacteria that pose the greatest health threats.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2017-02-28       Impact factor: 49.962

2.  Vaccine against toxic shock syndrome in a first-in-man clinical trial.

Authors:  Andreas Roetzer; Bernd Jilma; Martha M Eibl
Journal:  Expert Rev Vaccines       Date:  2016-12-15       Impact factor: 5.217

Review 3.  Vaccine development to prevent Staphylococcus aureus surgical-site infections.

Authors:  N Mohamed; M Y Wang; J-C Le Huec; U Liljenqvist; I L Scully; J Baber; E Begier; K U Jansen; A Gurtman; A S Anderson
Journal:  Br J Surg       Date:  2017-01       Impact factor: 6.939

4.  Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase.

Authors:  Rebeccah S Lijek; Santiago L Luque; Qian Liu; Dane Parker; Taeok Bae; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

  4 in total
  1 in total

1.  The Anti-Staphylococcal Potential of Ethanolic Polish Propolis Extracts.

Authors:  Katarzyna Grecka; Piotr M Kuś; Piotr Okińczyc; Randy W Worobo; Justyna Walkusz; Piotr Szweda
Journal:  Molecules       Date:  2019-05-03       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.